Evidence map›Paper›PMID 34791838›Full record

ArticleESC heart failure2022

Identifying patients at increased risk for poor outcomes from heart failure with reduced ejection fraction: the PROMPT-HF risk model.

Adam D DeVore, Claude Larry Hill, Laine E Thomas, Nancy M Albert, Javed Butler, J Herbert Patterson, Adrian F Hernandez, Fredonia B Williams, Xian Shen, John A Spertus and 1 more

Open access · goldAbstract read
In one paragraph

Article in ESC heart failure, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 9 institutions in 1 country.

Adam D DeVoreDuke Clinical Research Institute, 200 Morris Street, Office 6318, Durham, NC, 27701, USA.
Claude Larry HillDuke Clinical Research Institute, 200 Morris Street, Office 6318, Durham, NC, 27701, USA.
Laine E ThomasDuke Clinical Research Institute, 200 Morris Street, Office 6318, Durham, NC, 27701, USA.
Nancy M AlbertCleveland Clinic, Cleveland, OH, USA.
Javed ButlerUniversity of Mississippi Medical Center, Jackson, MS, USA.
J Herbert PattersonEshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Adrian F HernandezDuke Clinical Research Institute, 200 Morris Street, Office 6318, Durham, NC, 27701, USA.
Fredonia B WilliamsMended Hearts, Huntsville, AL, USA.
Xian ShenNovartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
John A SpertusSaint Luke's Mid America Heart Institute and the University of Missouri-Kansas City, Kansas City, MO, USA.
Gregg C FonarowAhmanson-UCLA Cardiomyopathy Center, Ronald Reagan UCLA Medical Center, Los Angeles, CA, USA.
Clinical Research Institute · USCleveland Clinic · USDuke University · USHeartsong · USRonald Reagan UCLA Medical Center · USSaint Luke's Hospital · USTris Pharma (United States) · USUniversity of Mississippi Medical Center · USUniversity of North Carolina at Chapel Hill · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsWe aimed to develop a risk prediction tool that incorporated both clinical events and worsening health status for patients with heart failure (HF) with reduced ejection fraction (HFrEF). Identifying patients with HFrEF at increased risk of a poor outcome may enable proactive interventions that improve outcomes. METHODS AND

resultsWe used data from a longitudinal HF registry, CHAMP-HF, to develop a risk prediction tool for poor outcomes over the next 6 months. A poor outcome was defined as death, an HF hospitalization, or a ≥20-point decrease (or decrease below 25) in 12-item Kansas City Cardiomyopathy Questionnaire (KCCQ-12) overall summary score. Among 4546 patients in CHAMP-HF, 1066 (23%) experienced a poor outcome within 6 months (1.3% death, 11% HF hospitalization, and 11% change in KCCQ-12). The model demonstrated moderate discrimination (c-index = 0.65) and excellent calibration with observed data. The following variables were associated with a poor outcome: age, race, education, New York Heart Association class, baseline KCCQ-12, atrial fibrillation, coronary disease, diabetes, chronic kidney disease, smoking, prior HF hospitalization, and systolic blood pressure. We also created a simplified model with a 0-10 score using six variables (New York Heart Association class, KCCQ-12, coronary disease, chronic kidney disease, prior HF hospitalization, and systolic blood pressure) with similar discrimination (c-index = 0.63). Patients scoring 0-3 were considered low risk (event rate <20%), 4-6 were considered intermediate risk (event rate 20-40%), and 7-10 were considered high risk (event rate >40%).

conclusionsThe PROMPT-HF risk model can identify outpatients with HFrEF at increased risk of poor outcomes, including clinical events and health status deterioration. With further validation, this model may help inform therapeutic decision making.

Indexed as

Heart FailureHealth StatusHospitalizationHumansQuality of LifeStroke VolumeHeart failureLeft ventricular dysfunctionQuality of lifeRisk model

Identifiers

PMID34791838
PMCPMC8787961
OpenAlexW3212198429

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.